-
Diagnostics World News | At May’s Diagnostic Innovation Summit in Lisbon, Portugal, key opinion leaders will share the latest tools, clinical applications, and commercial product launches for liquid biopsies, infectious disease, and point-of-care testing. They will address regulatory changes, implementation challenges, and the path forward for diagnostic innovation.
Jan 17, 2020
-
Diagnostics World News | In 2012, Michael Snyder created an integrative personal omics profile, an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual. Today, Snyder is incorporating data from smart watches, continuous glucose monitoring, and other wearables to track people’s health and find early signs of disease.
Jan 16, 2020
-
Diagnostics World News | Despite the explosion of interest in the microbiome and the array of companies examining its composition, there remains an unmet clinical need for measuring microbiome function. And it’s a void Atmo Biosciences is looking to fill.
Jan 14, 2020
-
Diagnostics World News Contributed Commentary | The need for more accurate diagnostics for acute infections is clear, and several novel and promising diagnostic technologies have come to market recently, with more in the pipeline.
Jan 10, 2020
-
Diagnostics World News | As we head into 2020, we at Diagnostics World News would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.
Jan 9, 2020
-
Diagnostics World News | Caris announced the launch of its MI GPS (Genomic Profiling Similarity) Score, an AI-driven tumor type biology similarity score that uses a machine learning algorithm to compare molecular characteristics of a patient’s tumor against Caris’ database.
Jan 8, 2020
-
Diagnostics World News | Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology. Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies, and more.
Jan 7, 2020
-
Diagnostics World News | Last month NANOPEC Technologies announced MetaFluorex, a new class of proprietary nano-structured ceramic films, that the company says have shown to enhance fluorescent signals by factors as large as 100 times, depending on the assay, when compared to the glass slides currently used for in vitro diagnostic testing.
Jan 3, 2020
-
Diagnostics World News | A Duke University spin-out company is putting the last touches on a host response bacterial-viral test entering the final leg of the Antimicrobial Resistance (AMR) Diagnostic Challenge of the National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives.
Jan 2, 2020
-
Diagnostics World News | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Charles River, Takeda, Veracyte, and more.
Dec 23, 2019
-
Diagnostics World News | Researchers have known for a very long time that proteins circulating in human blood can, like the proverbial canary in the coal mine, be signals of health and disease risk. Until recently, the association has been exploited only in one-at-a-time experiments, usually with mass spectrometry technology.
Dec 19, 2019
-
Diagnostics World News | Ativa’s diagnostic workstation claims to be the only point-of-care system using a big-data approach to blood and urine testing to provide results on the major test panels used today to diagnose patients, and advanced diagnostic tests that gives deeper, more concise, disease information. If that sounds to you too good to be true, Ativa’s co-founder and CEO, is quick to point the company’s secrets to success: a team approach with solid partnerships, AI-driven analysis, and a seismic shift in the way data is collected for diagnostic testing.
Dec 18, 2019
-
Diagnostics World News | The Foundation for the National Institutes of Health is laser-focused on potentially transformative drug development tools that require group devotion to “not-so-sexy” science.
Dec 17, 2019